Dataset Information


Soluble miniagrin enhances contractile function of engineered skeletal muscle.

ABSTRACT: Neural agrin plays a pleiotropic role in skeletal muscle innervation and maturation, but its specific effects on the contractile function of aneural engineered muscle remain unknown. In this study, neonatal rat skeletal myoblasts cultured within 3-dimensional engineered muscle tissue constructs were treated with 10 nM soluble recombinant miniagrin and assessed using histological, biochemical, and functional assays. Depending on the treatment duration and onset time relative to the stage of myogenic differentiation, miniagrin was found to induce up to 1.7-fold increase in twitch and tetanus force amplitude. This effect was associated with the 2.3-fold up-regulation of dystrophin gene expression at 6 d after agrin removal and enhanced ACh receptor (AChR) cluster formation, but no change in cell number, expression of muscle myosin, or important aspects of intracellular Ca(2+) handling. In muscle constructs with endogenous ACh levels suppressed by the application of ?-NETA, miniagrin increased AChR clustering and twitch force amplitude but failed to improve intracellular Ca(2+) handling and increase tetanus-to-twitch ratio. Overall, our studies suggest that besides its synaptogenic function that could promote integration of engineered muscle constructs in vivo, neural agrin can directly promote the contractile function of aneural engineered muscle via mechanisms distinct from those involving endogenous ACh.


PROVIDER: S-EPMC3290432 | BioStudies | 2012-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2497462 | BioStudies
2011-01-01 | S-EPMC3069133 | BioStudies
2020-01-01 | S-EPMC7540925 | BioStudies
2012-01-01 | S-EPMC3359500 | BioStudies
2003-01-01 | S-EPMC6741189 | BioStudies
2007-01-01 | S-EPMC1924855 | BioStudies
2017-01-01 | S-EPMC5561360 | BioStudies
2008-01-01 | S-EPMC3225410 | BioStudies
2009-01-01 | S-EPMC2793544 | BioStudies
2008-01-01 | S-EPMC2743173 | BioStudies